Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

doi:10.1136/gutjnl-2020-321611

科研成果详情

题名	Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
作者	Giovanni Targher 1; Alessandro Mantovani 2; Christopher D Byrne 3; Xiao-Bo Wang4; Hua-Dong Yan 5; Qing-Feng Sun ; Ke-Hua Pan ; Kenneth I Zheng ; Yong-Ping Chen ; Mohammed Eslam ; Jacob George ; Ming-Hua Zheng
发表日期	2020-08-01
发表期刊	Gut 影响因子和分区
语种	英语
原始文献类型	Letter ; Comment
关键词	nonalcoholic steatohepatitis.
出版者	BMJ PUBLISHING GROUP
ISSN	0017-5749
EISSN	1468-3288
卷号	69 期号:8 页码:1545-1547.
DOI	10.1136/gutjnl-2020-321611
页数	3
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
WOS记录号	WOS:000557430800031
收录类别	PUBMED ; SCIE
URL	查看原文
PubMed ID	32414813
自科自定义期刊分类	T2(B)类
通讯作者地址	[Targher, Giovanni]Univ Verona, Dept Med Endocrinol & Metab, I-37126 Verona, Veneto, Italy. ; [Zheng, Ming-Hua]Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.
TOP期刊	TOP期刊
引用统计	被引频次：76[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/55453
专题	附属第一医院附属第一医院_感染内科
作者单位	1.Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy giovanni.targher@univr.it zhengmh@wmu.edu.cn.; 2.Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy.; 3.Southampton National Institute for Health Research Biomedical Research Centre, Southampton General Hospital, Southampton, Hampshire, UK.; 4.Department of Critical Care Medicine, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.; 5.Institute of Hepatology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
通讯作者单位	附属第一医院
推荐引用方式 GB/T 7714	Giovanni Targher,Alessandro Mantovani,Christopher D Byrne,et al. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores[J]. Gut,2020,69(8):1545-1547..
APA	Giovanni Targher., Alessandro Mantovani., Christopher D Byrne., Xiao-Bo Wang., Hua-Dong Yan., ... & Ming-Hua Zheng. (2020). Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut, 69(8), 1545-1547..
MLA	Giovanni Targher,et al."Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores".Gut 69.8(2020):1545-1547..